TrialPediatric blood & cancer2020

Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411).

Eric S Schafer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.